The current study has demonstrated that rCTII might substantially stimulate the apoptosis pathways, especially the intrinsic pathway, inhibit the expression of mir-214 and MMP-3, and suppress the TGF-β pathway via down-regulating SMAD2 and SMAD3 in melanoma. The gene discussed is SMAD3; the disease is melanoma.